Nuclear acetyl-CoA pools act as a bidirectional epigenetic thermostat governing organismal aging. ACLY-mediated acetyl-CoA generation drives pathological hypoacetylation at silent gene promoters, while ACSS2-mediated pools maintain protective hyperacetylation at active longevity gene loci. The ratio of nuclear ACLY:ACSS2 activity determines whether aging manifests as transcriptional silencing (senescence) or chromatin loosening (expression errors).
Aged MSCs show reduced nuclear acetyl-CoA from impaired mitochondrial citrate export via CiC, which silences osteogenic genes [1]. Middle-aged flies, by contrast, display histone overacetylation that increases expression errors [2]. These apparently contradictory findings likely reflect distinct enzymatic sources: the first stems from ACLY deficiency—citrate-derived acetyl-CoA that normally supports repressed genes—while the second may represent ACSS2 dysregulation, affecting acetate-derived acetyl-CoA at active loci. Calorie restriction illustrates this nicely: it decreases ACLY-derived cytoplasmic pools while increasing ACSS2-derived nuclear pools for longevity gene activation [3].
This mechanism proposes that ACLY and ACSS2 generate nuclear acetyl-CoA pools with non-overlapping genomic targeting. ACLY preferentially supplies acetyl-CoA to silenced gene promoters via p300/CBP, maintaining repressive histone marks that become deficient with age. ACSS2, meanwhile, supplies active enhancers and autophagy genes including TFEB targets [4]. Mitochondrial dysfunction during aging selectively impairs ACLY pathway flux without affecti





























